Twenty-four years of diligently collecting data at a high-volume UK hospital makes a strong case for intraoperative cell salvage (ICS) in complex hip revision cases — particularly since ICS appears to cut the incidence of allogeneic transfusions nearly in half.
In Intraoperative Cell Salvage for Revision Hip Arthroplasty: A 24-Year Study of Transfusion Requirements, Huntley and colleagues analyzed 2,639 revision procedures performed between 1996 and 2020. Intraoperative Cell Salvage was used in 28.6% of cases; the remaining cases served as contemporaneous controls.
Subscribe to continue reading
- Unlimited access to our content and archive
- Exclusive access to our newsletter
- Join the Conversation! Exclusive access to article comments.
